Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
![SZM-1209](https://www.biomol.com/media/image/9c/b6/e3/Cay38494-1_600x600.png)
Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
---|---|---|---|---|---|---|---|
Cay38494-1 | 1 mg | - |
6 - 10 business days* |
104.00€
|
|||
Cay38494-5 | 5 mg | - |
6 - 10 business days* |
410.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
SZM-1209 is an inhibitor of receptor-interacting serine/threonine kinase 1 (RIPK1). It... more
Product information "SZM-1209"
SZM-1209 is an inhibitor of receptor-interacting serine/threonine kinase 1 (RIPK1). It selectively binds to RIPK1 over RIPK3 (Kds = 85 and >10,000 nM, respectively) and inhibits necrosome formation and phosphorylation of RIPK1 induced by TNF-alpha, SM-164 (Cay-28632), and Z-VAD-FMK in HT-29 cells (EC50 = 22.4 nM). SMZ-1209 (10 and 20 mg/kg) decreases reductions in body temperature and improves survival in a mouse model of systemic inflammatory response syndrome (SIRS) induced by TNF-alpha and Z-VAD-FMK. It also reduces lung RIPK1 phosphorylation, IL-6 and TNF-alpha levels, and total protein content, as well as decreases the number of hemorrhagic sites and congestion edema, in a mouse model of acute lung injury (ALI) induced by short-term intratracheal exposure to 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK, Cay-16414).Formal Name: N-[5-[[2-[[[4-[(ethylsulfonyl)amino]cyclohexyl]carbonyl]amino]-5-fluoro-6-benzothiazolyl]oxy]-2-fluorophenyl]-3-(trifluoromethyl)-benzeneacetamide. CAS Number: 2919801-86-6. Molecular Formula: C31H29F5N4O5S2. Formula Weight: 696.7. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 15 mg/ml, DMSO: 10 mg/ml. SMILES: FC1=CC2=C(SC(NC(C3CCC(NS(CC)(=O)=O)CC3)=O)=N2)C=C1OC4=CC=C(F)C(NC(CC5=CC=CC(C(F)(F)F)=C5)=O)=C4. InChi Code: InChI=1S/C31H29F5N4O5S2/c1-2-47(43,44)40-20-8-6-18(7-9-20)29(42)39-30-38-25-15-23(33)26(16-27(25)46-30)45-21-10-11-22(32)24(14-21)37-28(41)13-17-4-3-5-19(12-17)31(34,35)36/h3-5,10-12,14-16,18,20,40H,2,6-9,13H2,1H3,(H,37,41)(H,38,39,42). InChi Key: GNCSJDDZYVYRGS-UHFFFAOYSA-N.
Keywords: | N-[5-[[2-[[[4-[(ethylsulfonyl)amino]cyclohexyl]carbonyl]amino]-5-fluoro-6-benzothiazolyl]oxy]-2-fluorophenyl]-3-(trifluoromethyl)-benzeneacetamide |
Supplier: | Cayman Chemical |
Supplier-Nr: | 38494 |
Properties
Application: | RIPK1 inhibitor |
MW: | 696.7 D |
Formula: | C31H29F5N4O5S2 |
Purity: | >98% |
Format: | Crystalline Solid |
Database Information
CAS : | 2919801-86-6| Matching products |
KEGG ID : | K02861 | Matching products |
Handling & Safety
Storage: | -20°C |
Shipping: | -20°C (International: -20°C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed